Clinical Variation in the Treatment Practices for Medication Nonadherence, Drug–Drug Interactions, and Recognition of Disease Progression in Patients with Chronic Cardiometabolic Diseases: A Cross-Sectional Patient Simulation Study among Primary Care Physicians

Table 3

Incorrect diagnosis of nonadherence versus DDI versus disease progression by case variant.

Case	Incorrectly diagnosed as nonadherence (%)	Incorrectly diagnosed as DDI (%)	Incorrectly diagnosed as disease progression (%)
Variant A—nonadherence (overall)	—	0	19.1
1A (atrial fibrillation)	—	0	0
2A (heart failure)	—	0	62.3
3A (diabetes/hypertension)	—	0	0
Variant B—DDI (overall)	7.5	—	13.3
1B (atrial fibrillation)	1.3	—	0
2B (heart failure)	12.4	—	33.7
3B (diabetes/hypertension)	8.1	—	0
Variant C—disease progression (overall)	1.3	1.8	—
1C (atrial fibrillation)	0	0	—
2C (heart failure)	0	3.0	—
3C (diabetes/hypertension)	3.6	2.4	—